View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
TUESDAY, May 5 (HealthDay News) -- Already a recognized risk factor for arterial thromboembolism, microalbuminuria also is a risk factor for venous thromboembolism (VTE), according to a study published in the May 6 issue of the Journal of the American Medical Association.
Bakhtawar K. Mahmoodi, of the University Medical Center in Groningen, Netherlands, and colleagues extracted data on 8,592 participants with higher levels of urinary albumin concentration from among the 40,856 respondents in the 1997 to 1998 Prevention of Renal and Vascular End-Stage Disease (PREVEND) study. The researchers used data from the regional anticoagulation clinic database to identify PREVEND subjects who developed VTE between 1997 and 2007.
Of the 8,574 participants who could be evaluated, the researchers found that 129 experienced VTE subsequent to PREVEND (mean follow-up period 8.6 years), reflecting an overall annual VTE incidence rate of 0.14 percent. The VTE annual incidence rate increased as urinary albumin excretion (UAE) increased: 0.12 percent (UAE less than 15 mg/24 h), 0.20 percent (UAE equal to 15 to 29 mg/24 h), 0.40 percent (UAE equal to 30 to 300 mg/24 h), and 0.56 percent (UAE greater than 300 mg/24 h).
"In conclusion, microalbuminuria is an independent risk factor for VTE. The relative risk of VTE associated with microalbuminuria is comparable to previously reported risk of myocardial infarction or stroke in individuals with microalbuminuria," the authors write.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top